A Bloodthinner That May Not Stop A Different Kind Of Bleeding
As Boehringer Ingelheim works feverishly to promote its Pradaxa bloodthinner before rival treatments are approved, a new study suggests the medication has a problem - cost. Treating patients with Pradaxa instead of warfarin, which is the decades-old standard of care, results in significantly higher costs per patient and higher net costs for each stroke that is avoided. (Source: Forbes.com Healthcare News)
Italy doctors save baby with smallest artificial heart
ROME (Reuters) - Italian doctors have saved the life of a 16-month-old boy by implanting the world's smallest artificial heart to keep the infant alive until a donor was found for a transplant. (Source: Reuters: Health)
